🔎 Trials Near Me

Home › Carcinoma a cellule squamose della testa e del collo › Oklahoma

Studi clinici su Carcinoma a cellule squamose della testa e del collo nello stato di Oklahoma

14 studi su Carcinoma a cellule squamose della testa e del collo cercano partecipanti presso sedi nello stato di Oklahoma.

Città nello stato di Oklahoma

Testo ufficiale dello studio (inglese)

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

  • University of Oklahoma Health Sciences Center, Oklahoma City
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06992427

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

  • Cancer Centers of Southwest Oklahoma Research, Lawton
  • University of Oklahoma Health Sciences Center, Oklahoma City
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06589804

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • University of Oklahoma Health Sciences Center, Oklahoma City
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT05136196

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

  • Stephenson Cancer Center, Oklahoma City
In reclutamentoFase 3
Età 60 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT04892173

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

  • Cancer Centers of Southwest Oklahoma Research, Lawton
  • University of Oklahoma Health Sciences Center, Oklahoma City
In reclutamentoFase 2
Età da 18 a 79 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT04671667

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

  • University of Oklahoma Health Sciences Center, Oklahoma City
  • Mercy Hospital Oklahoma City, Oklahoma City
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT02734537

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

  • Normunity Investigational Site, Oklahoma City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 ago 2026 · NCT07182149

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

  • University of Oklahoma Health Sciences Center, Oklahoma City
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT04333537

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

  • University of Oklahoma Health Sciences Center, Oklahoma City
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT06532279

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

  • SSM OKC Hightower Clinical, Oklahoma City
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 lug 2026 · NCT03526835

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • OU Health University of Oklahoma Medical Center, Oklahoma City
  • Stephenson Cancer Center (chemo location), Oklahoma City
  • University of Oklahoma Health Science Center, Oklahoma City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT04389632

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

  • GSK Investigational Site, Tulsa
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 26 mag 2026 · NCT06256588

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

  • Dren Investigational Site, Oklahoma City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 7 gen 2026 · NCT06999187

A Study of NX-1607 in Adults With Advanced Malignancies

  • University of Oklahoma, Oklahoma City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2025 · NCT05107674

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.